Rami Manochakian
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Rami Manochakian
Jul 21, 2024, 13:36 |
Blog
Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint
Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…
Jul 6, 2024, 12:30 |
Opinion
Discussions around ABIM MOC
The discussions among ABIM's Maintaining Certification (MOC) program continue on X/Twitter. This time a conversation…
Jul 2, 2024, 15:18 |
Blog
Rami Manochakian: 7 excellent peer-reviewed Lung Cancer articles from ASCO24 Educational Book
Rami Manochakian shared on X: "Check out these 7 excellent peer-reviewed Lung Cancer articles from ASCO24…
Jun 26, 2024, 06:12 |
Insight
Consensus Recommendations from IASLC on neoadjuvant and adjuvant treatment for NSCLC
Rami Manochakian shared a post on X: “Hot off the press! Just published in JTO and…
Jun 14, 2024, 14:08 |
Blog
Rami Manochakian: Results of PALOMA3 study by Natasha B. Leighl et al
Rami Manochakian shared a post on X: "Hot off the press. Just published in Journal of…
Jun 11, 2024, 11:53 |
Societies
Mayo Clinic and American Hospital Dubai will host the fifth annual International Oncology Summit in Dubai
Mayo Clinic recently shared a post on LinkedIn: "Mayo Clinic and American Hospital Dubai, a…
Jun 6, 2024, 23:45 |
Blog
M. Talha Ugurlu: I attended the Advancements in Oncology event by Oncology Brothers
M. Talha Ugurlu, Internal Medicine resident at Tufts School of Medicine, shared a post on X:…
Jun 5, 2024, 15:09 |
Societies
15 Posts From ASCO24 Day 5 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 5, 2024, 11:11 |
Societies
Rami Manochakian: ASCO24 is over but ASCO’s great mission in conquering cancer is ongoing
Rami Manochakian shared a post on X: “Incredible American Society of Clinical Oncology 2024 (ASCO24) is…
Jun 2, 2024, 23:31 |
Societies
Rami Manochakian receives the distinction of FASCO at ASCO24
Rami Manochakian shared on their X/Twitter: "I’m honored and humbled to receive the distinction of FASCO…
Jun 2, 2024, 09:09 |
Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 28, 2024, 15:10 |
Blog
Rami Manochakian: I’m honored to chair the upcoming ASCO24 Case-Based Panel Lung cancer Education Session
Rami Manochakian shared on their X/Twitter: ''Hot off the press. Thank you ASCO Daily News…
May 28, 2024, 07:41 |
Blog
Margaret Gatti-Mays: How presented data at ASCO24 will impact clinical care in oncology clinics
Margaret Gatti-Mays, Co-Director of the Division of Medical Oncology at the Ohio State University, shared a…
May 25, 2024, 02:57 |
Blog
Rami Manochakian: Join us at the Annual meeting of ASCO OncMedEdCoP during ASCO24
Rami Manochakian shared a post by ASCO OncMedEdCoP on X/Twitter: "Alerting colleagues, Oncologists and Trainees with…
May 24, 2024, 20:02 |
Insight
Rami Manochakian: Launching an International Community of Practice in Hematology Oncology, Medical Education
Rami Manochakian shared on X/Twitter: "Hot off the press. Excited to share this just published paper…
May 22, 2024, 14:07 |
Blog
How the data from ASCO24 is going to change our practice - Oncology Brothers
Oncology Brothers shared on X: "Let's talk how the data from ASCO24 is going to…
May 21, 2024, 11:58 |
Insight
Rami Manochakian: New Guidelines by the American Society of Clinical Oncology and the Society for Integrative Oncology
Rami Manochakian recently shared a post on X: "Hot off the Press. New Guidelines by…
May 19, 2024, 07:07 |
Blog
Eric K. Singhi: High-yield IASLC Academy session
Eric K. Singhi shared the following on X: “High-yield IASLC Academy session this morning. ACCE(ing) your…
May 18, 2024, 08:33 |
Blog
Rami Manochakian: Results of Checkmate 77T trial of
Rami Manochakian shared a post on X/Twitter: ''Hot Off The Press. Just published at NEJM.…
May 6, 2024, 08:18 |
Blog
Margaret Gatti-Mays: Excited to be part of this amazing program
Margaret Gatti-Mays, Co-Director of The Ohio State Uiversity Division of Medical Oncology, shared a post by…
Apr 28, 2024, 16:53 |
Blog
Rami Manochakian: Three Plenary Session Presentations on Lung Cancer at ASCO24
Rami Manochakian shared a post on X: "ASCO 2024 annual meeting's abstracts just released. Three…
Apr 26, 2024, 10:07 |
Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 23, 2024, 14:25 |
Blog
Fernando Diaz: Trainees let's step up and log in to the ACT Network to write to our legislators
Fernando Diaz, Geriatric-Oncology Fellow at University of North Carolina, shared a post on X/Twitter by…
Apr 23, 2024, 11:04 |
Blog
Rami Manochakian: Another great ASCO Advocacy Summit is over but OUR WORK IS NOT OVER
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: "THANK YOU…
Apr 20, 2024, 01:14 |
Societies
Alejandra Perez: Team Florida at ASCO Advocacy Summit
Estela Rodriguez shared a post by Alejandra Perez, Director of the Braman Family Breast Cancer…
Apr 19, 2024, 06:25 |
Drugs
,
Opinion
Rami Manochakian: The Drug Shortage crisis
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: "The Drug…
Apr 16, 2024, 07:13 |
Career
Rami Manochakian: Thank you ASCO for naming me a 2023 Advocacy Champion
Rami Manochakian, Associate Professor, Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: "Thank you ASCO for…
Apr 13, 2024, 09:40 |
Drugs
Rami Manochakian: Results of adjuvant Alectinib vs Chemotherapy in resected ALK+ stage IB-IIIA NSCLC
Rami Manochakian, thoracic medical oncologist at Mayo Clinic, shared a post on X: "Hot off…
Apr 8, 2024, 16:20 |
Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Mar 28, 2024, 02:31 |
Insight
Rami Manochakian: New Supportive Care Guideline by ASCO on Vaccination of adult with cancer
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: "Hot off…
Mar 9, 2024, 12:35 |
Blog
Rami Manochakian: The future of Thoracic Oncology is in great hands!
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “The future of Thoracic…
Mar 6, 2024, 11:34 |
Drugs
Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Mar 2, 2024, 23:40 |
Blog
Rami Manochakian: ASCO Living Guideline Update by great experts Journal of Clinical Oncology
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Feb 28, 2024, 12:30 |
Blog
Rami Manochakian: I signed ASCO’s letter to end Drug Shortages
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "I signed ASCO’s letter…
Feb 17, 2024, 15:57 |
Insight
Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…
Feb 11, 2024, 18:41 |
History
Insights from the World Cancer Day, Feb 4
OncoDaily features some insights from around the world on the World Cancer Day, Feb 4:…
Dec 29, 2023, 11:13 |
Blog
Rami Manochakian: The 10 most-read articles of The ASCO Post in 2023
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "The 10 most-read…
Dec 17, 2023, 23:50 |
Blog
Rami Manochakian: Thank You Oncology Brothers for putting together important Cancer Education sessions for the Oncology community
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared the following post by Oncology…
Dec 3, 2023, 16:39 |
Insight
Rami Manochakian: A special supplement highlighting major data from the IASLC 2023
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…
Nov 15, 2023, 18:19 |
Blog
Rami Manochakian: On Saturday, November 18th, our team is hosting a free Cancer Education Symposium for patients with lung cancer and caregivers
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Next week, on Saturday,…
Nov 12, 2023, 16:59 |
Opinion
Rami Manochakian: I’m honoured and humbled to earn the distinction of FASCO
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared on X/Twitter: “I’m honoured and humbled…
Oct 15, 2023, 19:05 |
Blog
Rami Manochakian: ASCO Podcast episode on the recently published
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared on X/Twitter: "Hot off the press!…
Oct 14, 2023, 18:23 |
Blog
Rami Manochakian: NEW ASCO and Ontario Health Guideline on Systemic Therapy for Small Cell Lung Cancer.
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared on X/Twitter: "Hot off the press…
Oct 13, 2023, 17:10 |
Drugs
Rami Manochakian: FDA Oncology approves the combination of Encorafenib and Binimetinib for Patients with metastatic Non-Small cell Lung Cancer with a BRAF V600E mutation.
Oct 10, 2023, 16:00 |
Blog
Rami Manochakian: FREE LIVE - "Cancer Education Symposium" for Patients with Lung Cancer and care givers on Saturday November 18th at the Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Florida.
Oct 4, 2023, 17:57 |
Insight
Rami Manochakian: Takeda Oncology announced voluntary WITHDRAWAL of Mobocertinib (in the US and globally) for patients with advanced EGFR, Exon20 insertion mutation-positive non-small cell lung cancer, after negative exclaim2 trial.
Sep 14, 2023, 18:08 |
Blog
,
Stories
Top 9 posts you dont wanna wiss from WCLC
The 2023 World Conference on Lung Cancer took place in Singapore from September 9-12. Our…
Sep 2, 2023, 19:39 |
Insight
Rami Manochakian: When NOT having a tissue may not be an issue in advanced lung cancer
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, recently shared on Twitter: "Hot off the…
Aug 16, 2023, 19:31 |
Societies
Mark your calendars for our FIRST live lung cancer journal club discussing updated results from the ADAURA trial - LungCancerRx
Quoting a post from Twitter user "LungCancerRx": "Exciting News! Mark your calendars for our FIRST…
Aug 3, 2023, 19:24 |
Blog
Top 10 World Lung Cancer Day Tweets you shouldn't miss
On World Lung Cancer Day, which falls on August 1, OncoDaily selected 10 important tweets…
Aug 1, 2023, 06:22 |
Blog
It’s an “ERA OF HOPE” for patients with Lung Cancer - Rami Manochakian
Today is World Lung Cancer Day. It’s an “ERA OF HOPE” for patients with Lung…
Jul 30, 2023, 06:18 |
Career
Excited to kick off the 32 annual Mayo Cancer Care Florida Hematology/Oncology Reviews 2023 - Rami Manochakian
Excited to kick off the 32 annual Mayo Cancer Care Florida Hematology/Oncology Reviews 2023. Comprehensive…
Jun 30, 2023, 19:08 |
Drugs
Perioperative Nivolumab and Chemotherapy in stage III Non-Small-Cell Lung Cancer
In a post by Rami Manochakian on Twitter, it says, "Just published NEJM Results of…
Jun 7, 2023, 10:31 |
Insight
After TKI , adding Pembro to chemo DOES NOT improve OS - Rami Manochakian
NEGATIVE results of Keynote789 trial: Platinum + Pem +/- Pembro for TKI-resistant EGFR mutant NSCLC…
All:
54
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube